Thromb Haemost 1995; 74(01): 213-217
DOI: 10.1055/s-0038-1642679
Colloquium
Platelets,Leukocytes and Endothelial Cells During Inflammation and Thrombosis
Schattauer GmbH Stuttgart

Thrombosis and Inflammation as Multicellular Processes: Significance of Cell-Cell Interactions

Aaron J Marcus
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Lenore B Safier
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
M Johan Broekman
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Naziba Islam
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Joan H Fliessbach
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Katherine A Hajjar
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Wolfgang E Kaminski
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Ellen Jendraschak
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Roy L Silverstein
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
,
Clemens von Schacky
Thrombosis Research Laboratory, Departement of Veterans Affairs Medical Center, New York, NY, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

 
  • References

  • 1 Marcus AJ, Hajjar DP. Vascular transcellular signalling. J Lipid Res 1993; 34: 2017-2032
  • 2 Marcus AJ, Safier LB. Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993; 7: 516-522
  • 3 Marcus AJ, Safier LB, Broekman MJ, Ullman HL, Islam N, Sorrell TC, Sefhan CN, Weissmann G, Oglesby TD, Gorman RR. Production of metabolic products of arachidonic acid during cell-cell interactions. J Allergy Clin Immunol 1984; 74: 338-342
  • 4 Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-123
  • 5 Habib A, Maclouf J. Comparison of leukotriene A4metabolism into leukotriene C4 by human platelets and endothelial cms. Arch Biochem Biophys 1992; 298: 1-9
  • 6 Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Serhan CN, Rutherford LE, Korchak HM, Weissmann G. Formation ofleukotrienes and otherhydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun 1982; 109: 130-137
  • 7 Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension. Blockade of aggregation and secretion by an aspirin-insensitive mechanism Blood 1991; 78: 1033-1040
  • 8 Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J din Invest 1980; 66: 979-986
  • 9 Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosandd production by intact erythrocytes. J Clin Invest 1991; 87: 571-580
  • 10 Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Aznar J. Down-regulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993; 92: 1357-1365
  • 11 Crouch MF, Lapetina EG. A role for Gi in control of thrombin receptor- phospholipase C coupling in human platelets. J Biol Chem 1988; 263: 3363-3371
  • 12 Nicosia S, Patrono C. Eicosanoid biosynthesis and action: novel opportunities for pharmacological intervention. FASEB J 1989; 3: 1941-1948
  • 13 Valles J, Santos MT, Aznar J, Marcus AJ, Safier LB, Broekman MJ. Effects of different doses of aspirin on "ex vivo" platelet recruitment. Modulatory role of erythrocytes Thromb Haemost 1993; 69: 633 (Abstract)
  • 14 Minowada G, Welch WJ. Clinical Implications of the stress response. J Clin Invest 1995; 95: 3-912
  • 15 AntiPlatelet Trialists ’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106
  • 16 AntiPlatelet Trialists ’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994; 308: 159-168
  • 17 Steering Committee of the Physicians ’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med 1989; 321: 129-135
  • 18 Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells J Clin Invest 1991; 88: 1690-1696
  • 19 Marcus AJ. Eicosanoid interactions between platelets, endothelial cells, and neutrophils. Meth Enz 1990; 187: 585-598
  • 20 Serhan CN. Components of the arachidonic acid signalling cascade: a brief update and hypothesis. In: Bayer Rheuma Workshop: Trends in RA- Research. Hedqvist P, Kalden JR, Muller-Peddinghaus R, Robinson DR. eds. Eular Publishers; Basel: 1991: 141-153
  • 21 Maclouf J, Murphy RC, Henson PM. Transcellularsulfidopeptideleukotriene biosynthetic capacity of vascular cells. Blood 1989; 74: 703-707
  • 22 Maclouf J, Murphy RC, Henson PM. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation ofhuman neutrophil/platelet mixtures. Blood 1990; 76: 1838-1844
  • 23 Patrono C. Aspirin and human platelets: From clinical trials to acetylation of cyclooxygenase and back. TIPS 1989; 10: 453-458
  • 24 Myler RK, Frink RJ, Shaw RE, Bashour TT, Hecht HS, Ryan C, Cumberl DC, Stertzer SH. The unstable plaque: Pathophysiology and therapeutic implications. J Invas Cardiol 1990; 2: 117-128
  • 25 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
  • 26 Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 610-614
  • 27 Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 1977; 59: 149-158
  • 28 Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
  • 29 Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ Res 1993; 73: 217-222
  • 30 Ignarro LJ. Nitric oxide-mediated vasorelaxation. Thromb Haemost 1993; 70: 148-151
  • 31 Nathan C, Xie Q-w. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728
  • 32 Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olson SL, Lu WC, Kau C-L, Marsden PA. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 1994; 269: 33082-33090
  • 33 Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41
  • 34 Busse R, Miilsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993; 87 (05) 18-25
  • 35 Moncada S, Palmer RM J, Higgs EA. Biosynthesis of nitric oxide from L- arginine. A pathway for the regulation of cell function and communication Biochem Pharmacol 1989; 38: 1709-1715
  • 36 Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium -dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664
  • 37 Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992; 86: 1302-1309
  • 38 Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064
  • 39 Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-14522
  • 40 Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348-6352
  • 41 Bassenge E. Clinical relevance of endothelium-derived relaxing factor (EDRF). Br J Clin Phamiacol 1992; 34 (01) 37-42
  • 42 Maurice DH, Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 1990; 37: 671-681
  • 43 Moncada S. Nitric oxide gas: Mediator, modulator, and pathophysiologic entity. J Lab Clin Med 1992; 120: 187-191
  • 44 Coade SB Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989; 65: 531-537
  • 45 Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL. The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface J Biol Chem 1989; 264: 18986-18992
  • 46 Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986; 233: 309-319
  • 47 Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ. Thromboregulation by endothelial cells: Properties of an aspirin-insensitive endothelial cell membrane ADPase. Thromb Haemostas 1993; 69: 641 (Abstract)
  • 48 Law JH, Ribeiro JM C, Wells MA. Biochemical insights derived from insect diversity. Annu Rev Biochem 1992; 61: 87-111
  • 49 Ribeiro JM C, Rossignol PA, Spielman A. Salivary gland apyrase determines probing time in anopheline mosquitoes. J Insect Physiol 1985; 31: 689-692
  • 50 Lin S-H, Guidotti G. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase: The primaiy structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J Biol Chem 1989; 264: 14408-14414
  • 51 Culic O, Huang Q-H, Fanagan D, Hixson D, Lin S-H. Molecular cloning and expression of a new rat liver cell-CAM105 isoform. Biochem J 1992; 285: 47-53
  • 52 Cheung PH, Thompson NL, Culic O, Hixson D, Lin S-H. Cell-CAM105 isofoims with different adhesion functions are coexpressed in adult rat tissues and during liver development. J Biol Chem 1993; 268: 6139-6146
  • 53 Hinoda Y, Neumaier M, Hefta SA, Drzeniek Z, Wagener C, Shively L, Hefta LJ F, Shively JE, Paxton RJ. Molecular cloning of a cDNA coding biliary glycoprotein I: Primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen. Proc Natl Acad Sci USA 1988; 85: 6959-6963
  • 54 Marcus AJ. Dr. Eli Moschcowitz. In: Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. Kaplan BS, Trompeter RS, Moake JL. eds. Marcel Dekker; Inc New York: 1992: 19-27